Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 38-42 , 15 January 2008

The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population

  • Zheng Liu
    • ,
  • Jianping Jia

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. Tel.: +86 10 83198730; fax: +86 10 83171070.

Received 29 January 2007 ,Revised 24 June 2007 ,Accepted 28 June 2007.

References 

  1. Tandon A, Rogaeva E, Mullan M, St George-Hyslop PH. Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Curr Opin Neurol. 2000;13:377–384
  2. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467–1472
  3. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356
  4. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996;2:864–870
  5. Athan ES, Lee JH, Arriaga A, Mayeux RP, Tycko B. Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease. Arch Neurol. 2002;59:1793–1799
  6. Lahiri DK, Ghosh C, Ge YW. A proximal gene promoter region for the beta-amyloid precursor protein provides a link between development, apoptosis, and Alzheimer's disease. Ann NY Acad Sci. 2003;1010:643–647
  7. Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology. 2002;59:59–66
  8. Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, et al. Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol Psychiatry. 2002;7:886–890
  9. Theuns J, Remacle J, Killick R, Corsmit E, Vennekens K, Huylebroeck D, et al. Alzheimer-associated C allele of the promoter polymorphism −22C>T causes a critical neuron-specific decrease of presenilin 1 expression. Hum Mol Genet. 2003;12:869–877
  10. van Duijn CM, Cruts M, Theuns J, Van Gassen G, Backhovens H, van den Broeck M, et al. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. Eur J Hum Genet. 1999;7:801–806
  11. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet. 2006;78:936–946
  12. Lv H, Jia L, Jia J. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease. Neurobiol Aging. 2006;
  13. Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, et al. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet. 2002;107:201–208
  14. Wang CK, Chen CM, Chang CY, Chang KH, Chen IC, Li ML, et al. Alpha-synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease. J Neural Transm. 2006;113:1425–1433
  15. Riazanskaia N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y, et al. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Mol Psychiatry. 2002;7:891–898
  16. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  18. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11:298–300, 302.
  19. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158–1159
  20. Di Natale M, Perri M, Kawarai T, Maletta R, Tomaino C, Sato C, et al. Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian population. Neurosci Lett. 2003;343:210–212
  21. Quan W, Yasuda M, Hashimoto M, Yamamoto Y, Ishii K, Kazui H, et al. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study. J Neurol Sci. 2006;240:71–75
  22. Levy-Lahad E, Poorkaj P, Wang K, Fu Y, Oshima J, Mulligan J, et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. Genomics. 1996;34:198–204
  23. Lukiw WJ, Gordon WC, Rogaev EI, Thompson H, Bazan NG. Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis. Neuroreport. 2001;12:53–57
  24. Wang H, Qu X, De Plaen IG, Hsueh W. Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. Br J Pharmacol. 2001;133:713–721
  25. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775–778
  26. Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5:985–988

PII: S0022-510X(07)00484-4

doi: 10.1016/j.jns.2007.06.054

Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 38-42 , 15 January 2008

Article Tools

* Image Usage & Resolution